Loss of morphine hyperphagia following neonatal monosodium glutamate treatment in rats

Life Sci. 1986 Mar 10;38(10):947-50. doi: 10.1016/0024-3205(86)90264-x.

Abstract

Morphine stimulates food intake in mildly-deprived and nondeprived rats. Neonatal administration of monosodium glutamate (MSG) destroys the medial-basal hypothalamus and other circumventricular organs, including cells containing beta-endorphin that project to other hypothalamic nuclei proposed in the modulation of morphine hyperphagia. Food intake of MSG-treated and control rats were assessed following vehicle and morphine (1.0-5.0 mg/kg, sc) treatment in a mild (5h) food deprivation paradigm. Morphine hyperphagia was found to be absent in MSG-treated rats, although they responded normally to mild deprivation following vehicle treatment. These results add to the types of ingestive deficits observed in the MSG-treated rat, and suggest that the circumventricular system in general, and opioid medial-basal hypothalamic cells in particular may be implicated in morphine hyperphagia.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Arcuate Nucleus of Hypothalamus / drug effects
  • Arcuate Nucleus of Hypothalamus / pathology
  • Eating / drug effects*
  • Female
  • Food Deprivation
  • Glutamates / pharmacology*
  • Hypothalamus, Middle / drug effects
  • Hypothalamus, Middle / physiology
  • Median Eminence / drug effects
  • Median Eminence / pathology
  • Morphine / pharmacology*
  • Necrosis
  • Rats
  • Sodium Glutamate / pharmacology*

Substances

  • Glutamates
  • Morphine
  • Sodium Glutamate